NCT04132505 2026-04-06
Binimetinib and Hydroxychloroquine in Treating Patients With KRAS Mutant Metastatic Pancreatic Cancer
M.D. Anderson Cancer Center
Phase 1 Completed
M.D. Anderson Cancer Center
Emory University
The University of Texas Health Science Center at San Antonio
Abramson Cancer Center at Penn Medicine
RedHill Biopharma Limited